Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.

A. L. Brackenridge, N. Jackson, W. Jefferson, M. Stolinski, F. Shojaee-Moradie, R. Hovorka, A. M. Umpleby, D. Russell-Jones

    Research output: Contribution to journalArticlepeer-review

    Abstract

    In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.
    Original languageEnglish
    Pages (from-to)532-539
    JournalDiabetic Medicine
    Volume26
    Issue number5
    DOIs
    Publication statusPublished - May 2009

    Keywords

    • Allied health professions and studies

    Fingerprint

    Dive into the research topics of 'Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.'. Together they form a unique fingerprint.

    Cite this